MR and CT evaluation of cardiovascular risk in metabolic syndrome

Abstract

Early identification of patients with subclinical cardiovascular or cerebrovascular disease manifestation is highly relevant as organ damage might still be reversible. Imaging can be used for risk stratification and optimizing individual prevention and treatment strategies in patients with metabolic syndrome. This thesis evaluates MR and CT imaging techniques for identifying risk factors and subclinical disease in metabolic syndrome.